292 related articles for article (PubMed ID: 22860993)
1. Novel therapeutic targets in chordoma.
Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
[TBL] [Abstract][Full Text] [Related]
2. Notochordal Tumors: An Update on Molecular Pathology with Therapeutic Implications.
Yamaguchi T; Imada H; Iida S; Szuhai K
Surg Pathol Clin; 2017 Sep; 10(3):637-656. PubMed ID: 28797506
[TBL] [Abstract][Full Text] [Related]
3. T (brachyury) gene duplication confers major susceptibility to familial chordoma.
Yang XR; Ng D; Alcorta DA; Liebsch NJ; Sheridan E; Li S; Goldstein AM; Parry DM; Kelley MJ
Nat Genet; 2009 Nov; 41(11):1176-8. PubMed ID: 19801981
[TBL] [Abstract][Full Text] [Related]
4. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
Gill CM; Fowkes M; Shrivastava RK
Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
[TBL] [Abstract][Full Text] [Related]
6. 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#).
Szuhai K; Hogendoorn PC
J Pathol; 2012 Nov; 228(3):261-5. PubMed ID: 22952146
[TBL] [Abstract][Full Text] [Related]
7. [Novel molecular aspects of chordomas].
Scheil-Bertram S
Pathologe; 2014 Nov; 35 Suppl 2():237-41. PubMed ID: 25394972
[TBL] [Abstract][Full Text] [Related]
8. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM
J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613
[TBL] [Abstract][Full Text] [Related]
9. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.
Hsu W; Mohyeldin A; Shah SR; ap Rhys CM; Johnson LF; Sedora-Roman NI; Kosztowski TA; Awad OA; McCarthy EF; Loeb DM; Wolinsky JP; Gokaslan ZL; Quiñones-Hinojosa A
J Neurosurg; 2011 Oct; 115(4):760-9. PubMed ID: 21699479
[TBL] [Abstract][Full Text] [Related]
10. The driver landscape of sporadic chordoma.
Tarpey PS; Behjati S; Young MD; Martincorena I; Alexandrov LB; Farndon SJ; Guzzo C; Hardy C; Latimer C; Butler AP; Teague JW; Shlien A; Futreal PA; Shah S; Bashashati A; Jamshidi F; Nielsen TO; Huntsman D; Baumhoer D; Brandner S; Wunder J; Dickson B; Cogswell P; Sommer J; Phillips JJ; Amary MF; Tirabosco R; Pillay N; Yip S; Stratton MR; Flanagan AM; Campbell PJ
Nat Commun; 2017 Oct; 8(1):890. PubMed ID: 29026114
[TBL] [Abstract][Full Text] [Related]
11. From notochord formation to hereditary chordoma: the many roles of Brachyury.
Nibu Y; José-Edwards DS; Di Gregorio A
Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285
[TBL] [Abstract][Full Text] [Related]
12. T gene isoform expression pattern is significantly different between chordomas and notochords.
Wang K; Hu Q; Wang L; Chen W; Tian K; Cao C; Wu Z; Jia G; Zhang L; Zeng C; Zhang J
Biochem Biophys Res Commun; 2015 Nov; 467(2):261-7. PubMed ID: 26435504
[TBL] [Abstract][Full Text] [Related]
13. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma.
Kelley MJ; Shi J; Ballew B; Hyland PL; Li WQ; Rotunno M; Alcorta DA; Liebsch NJ; Mitchell J; Bass S; Roberson D; Boland J; Cullen M; He J; Burdette L; Yeager M; Chanock SJ; Parry DM; Goldstein AM; Yang XR
Hum Genet; 2014 Oct; 133(10):1289-97. PubMed ID: 24990759
[TBL] [Abstract][Full Text] [Related]
14. Chordoma: current concepts, management, and future directions.
Walcott BP; Nahed BV; Mohyeldin A; Coumans JV; Kahle KT; Ferreira MJ
Lancet Oncol; 2012 Feb; 13(2):e69-76. PubMed ID: 22300861
[TBL] [Abstract][Full Text] [Related]
15. Clinical findings in families with chordoma with and without T gene duplications and in patients with sporadic chordoma reported to the Surveillance, Epidemiology, and End Results program.
Parry DM; McMaster ML; Liebsch NJ; Patronas NJ; Quezado MM; Zametkin D; Yang XR; Goldstein AM
J Neurosurg; 2020 Jun; 134(5):1399-1408. PubMed ID: 32559743
[TBL] [Abstract][Full Text] [Related]
16. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
[TBL] [Abstract][Full Text] [Related]
17. Genomic and transcriptomic characterization of skull base chordoma.
Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
[TBL] [Abstract][Full Text] [Related]
18. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
[TBL] [Abstract][Full Text] [Related]
19. Chordoma: the entity.
Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y
Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090
[TBL] [Abstract][Full Text] [Related]
20. Brachyury and chordoma: the chondroid-chordoid dilemma resolved?
Romeo S; Hogendoorn PC
J Pathol; 2006 Jun; 209(2):143-6. PubMed ID: 16604512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]